Abstract:Cold atmospheric plasma emerges as a cancer therapy that can activate and enhance anti‐tumor immune responses through different mechanisms. This ensures durable and systemic therapeutic effects. This review presents a comprehensive summary of immune‐response promoting mechanisms of plasma therapy, the limitations of current plasma modalities, and cutting‐edge developments in plasma‐treated hydrogels as a novel, minimally‐invasive modality to treat non‐surface tumors. Cold atmospheric plasma (CAP) is a partially ionized gas that gains attention as a well‐tolerated cancer treatment that can enhance anti‐tumor immune responses, which are important for durable therapeutic effects. This review offers a comprehensive and critical summary on the current understanding of mechanisms in which CAP can assist anti‐tumor immunity: induction of immunogenic cell death, oxidative post‐translational modifications of the tumor and its microenvironment, epigenetic regulation of aberrant gene expression, and enhancement of immune cell functions. This should provide a rationale for the effective and meaningful clinical implementation of CAP. As discussed here, despite its potential, CAP faces different clinical limitations associated with the current CAP treatment modalities: direct exposure of cancerous cells to plasma, and indirect treatment through injection of plasma‐treated liquids in the tumor. To this end, a novel modality is proposed: plasma‐treated hydrogels (PTHs) that can not only help overcome some of the clinical limitations but also offer a convenient platform for combining CAP with existing drugs to improve therapeutic responses and contribute to the clinical translation of CAP. Finally, by integrating expertise in biomaterials and plasma medicine, practical considerations and prospective for the development of PTHs are offered.

Advantages of Cold Atmospheric Plasma Jet Generated by Positive Pulse Voltage in Anti-Cancer Therapy

Pulsed voltage cold atmospheric plasma jet and gold nanoparticles enhance cytotoxic anticancer effect

Pulsed voltage cold atmospheric plasma jet and goldnanoparticles enhance cytotoxic anticancer effect

Cytotoxic Activity of a Cold Atmospheric Plasma Jet in Relation to a 3D Cell Model of Human Breast Cancer

Preclinical Cold Atmospheric Plasma Cancer Treatment

Experimental study of a microsecond-pulsed cold plasma jet

A Microsecond-Pulsed Cold Plasma Jet for Medical Application

Principles of using Cold Atmospheric Plasma Stimulated Media for Cancer Treatment

Cold atmospheric plasma discharged in water and its potential use in cancer therapy

A New Physically Triggered Cell Death via Transbarrier Contactless Cold Atmospheric Plasma Treatment of Cancer Cells

Atmospheric pressure plasma jets applied to cancerology: correlating electrical configurations with in vivo toxicity and therapeutic efficiency

Cold Atmospheric Plasma Changes the Amino Acid Composition of Solutions and Influences the Anti-Tumor Effect on Melanoma Cells

Clinical application of cold atmospheric-pressure plasma: mechanisms and irradiation conditions

Intracellular Responses Triggered by Cold Atmospheric Plasma and Plasma-Activated Media in Cancer Cells

Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma

Micro-sized cold atmospheric plasma source for brain and breast cancer treatment

Cold Atmospheric Plasma Activates Selective Photothermal Therapy of Cancer

Air cold atmospheric plasma with patterns for anaplastic squamous cell carcinoma treatment

Current State of Cold Atmospheric Plasma and Cancer‐Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels

Comparison of the anticancer effects between helium plasma jets and electrochemical treatment (EChT)

Utilizing the micron sized non-thermal atmospheric pressure plasma inside the animal body for the tumor treatment application